Prescription drug · ANDA
Methazolamide NDC 24208-023
Methazolamide 50 mg/1 · Tablet · Oral · Bausch & Lomb Incorporated
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 24208-023-01 | 24208002301 | 1000 TABLET in 1 BOTTLE (24208-023-01)Marketed from Oct 2, 2020 | |
| 24208-023-10 | 24208002310 | 100 TABLET in 1 BOTTLE (24208-023-10)Marketed from Oct 2, 2020 | |
| 24208-023-50 | 24208002350 | 500 TABLET in 1 BOTTLE (24208-023-50)Marketed from Oct 2, 2020 | |
| 24208-023-90 | 24208002390 | 90 TABLET in 1 BOTTLE (24208-023-90)Marketed from Oct 2, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methazolamide
- Generic name (nonproprietary)
- methazolamide
- Active ingredients
- Methazolamide — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bausch & Lomb IncorporatedNDC labeler code 24208
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207438
- Marketing start
- Listing expires
- Identifiers
- Product ID 24208-023_41d745af-7d7b-dc08-e063-6394a90a2fbfSPL ID 41d745af-7d7b-dc08-e063-6394a90a2fbfSPL set ID 0c0ba5c7-c53e-4e29-a7ff-48fddc5a9258RxCUI 197939, 197940UNII W733B0S9SDUPC 0324208022108, 0324208023105
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N424208002301followed by a unit qualifier and the quantityPackage 24208-0023-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Methazolamide tablets are indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.
Excerpt only. Read the full label for complete information.
About NDC 24208-023
- What is NDC 24208-023?
- 24208-023 is the product NDC for Methazolamide, Methazolamide 50 mg/1 tablet, listed with the FDA by Bausch & Lomb Incorporated. It has 4 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Methazolamide.
- What is the active ingredient?
- Methazolamide.
- Who is the labeler?
- Bausch & Lomb Incorporated, NDC labeler code 24208. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Methazolamide?
- 19 other product NDCs are listed under this name. See all Methazolamide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Methazolamide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Methazolamide | Methazolamide 25 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-246 | 27241-0246-01 |
| Methazolamide | Methazolamide 50 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-247 | 27241-0247-01 |
| Methazolamide | Methazolamide 50 mg/1 | TabletOral | Precision Dose, Inc. | 68094-808 | 68094-0808-50 |
| Methazolamide | Methazolamide 25 mg/1 | TabletOral | Precision Dose, Inc. | 68094-908 | 68094-0908-50 |
| Methazolamide | Methazolamide 25 mg/1 | TabletOral | NorthStar Rx LLC | 72603-166 | 72603-0166-01 |
| Methazolamide | Methazolamide 50 mg/1 | TabletOral | NorthStar Rx LLC | 72603-167 | 72603-0167-01 |
| Methazolamide | Methazolamide 25 mg/1 | TabletOral | Bausch & Lomb Incorporated | 24208-022 | 24208-0022-0124208-0022-1024208-0022-50+1 more |
| Methazolamide | Methazolamide 25 mg/1 | TabletOral | Micro Labs Limited | 42571-239 | 42571-0239-0542571-0239-1042571-0239-90 |
| Methazolamide | Methazolamide 50 mg/1 | TabletOral | Micro Labs Limited | 42571-240 | 42571-0240-0542571-0240-1042571-0240-90 |
| Methazolamide | Methazolamide 25 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-1754 | 72162-1754-01 |
Other NDCs under ANDA 207438
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methazolamide | Methazolamide 25 mg/1 | TabletOral | Micro Labs Limited | 42571-239 |
| Methazolamide | Methazolamide 50 mg/1 | TabletOral | Micro Labs Limited | 42571-240 |
| Methazolamide | Methazolamide 25 mg/1 | TabletOral | Bausch & Lomb Incorporated | 24208-022 |